Status:
COMPLETED
ESP vs Retrolaminar Block: A Randomized Trial
Lead Sponsor:
Shaukat Khanum Memorial Cancer Hospital & Research Centre
Conditions:
Pain Management
Opoid Managment
Eligibility:
FEMALE
18-60 years
Phase:
NA
Brief Summary
The study aims to compare the efficacy in pain control and total opioid consumption after the use of ESPB and retrolaminar block in patients undergoing major oncological breast surgery..
Detailed Description
The study aims to compare the efficacy in pain control and total opioid consumption after the use of ESPB and retrolaminar block in patients undergoing major oncological breast surgery..
Eligibility Criteria
Inclusion
- Female patients between 18- 60 years ASA 1 and 2
Exclusion
- Patient refusal Allergic reaction infection emergency case BMI \>35
Key Trial Info
Start Date :
February 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2024
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT07200960
Start Date
February 1 2022
End Date
October 1 2024
Last Update
January 8 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shaukat Khanum Memorial Cancer Hospital & Research Centre.
Lahore, Punjab Province, Pakistan